CS244906B2 - Production method of antigen agent for limitation or prevention of tooth defects - Google Patents

Production method of antigen agent for limitation or prevention of tooth defects Download PDF

Info

Publication number
CS244906B2
CS244906B2 CS824558A CS455882A CS244906B2 CS 244906 B2 CS244906 B2 CS 244906B2 CS 824558 A CS824558 A CS 824558A CS 455882 A CS455882 A CS 455882A CS 244906 B2 CS244906 B2 CS 244906B2
Authority
CS
Czechoslovakia
Prior art keywords
antigen
cell walls
cell
sds
antibody
Prior art date
Application number
CS824558A
Other languages
Czech (cs)
English (en)
Other versions
CS455882A2 (en
Inventor
Roy R B Russel
Original Assignee
Secr Social Service Brit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Social Service Brit filed Critical Secr Social Service Brit
Publication of CS455882A2 publication Critical patent/CS455882A2/cs
Publication of CS244906B2 publication Critical patent/CS244906B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CS824558A 1981-06-19 1982-06-18 Production method of antigen agent for limitation or prevention of tooth defects CS244906B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8118886 1981-06-19

Publications (2)

Publication Number Publication Date
CS455882A2 CS455882A2 (en) 1985-09-17
CS244906B2 true CS244906B2 (en) 1986-08-14

Family

ID=10522633

Family Applications (1)

Application Number Title Priority Date Filing Date
CS824558A CS244906B2 (en) 1981-06-19 1982-06-18 Production method of antigen agent for limitation or prevention of tooth defects

Country Status (13)

Country Link
US (1) US4521513A (fr)
EP (1) EP0068660B1 (fr)
JP (1) JPS58500948A (fr)
AU (1) AU556184B2 (fr)
CA (1) CA1204384A (fr)
CS (1) CS244906B2 (fr)
DE (1) DE3263103D1 (fr)
DK (1) DK54483A (fr)
FI (1) FI77983C (fr)
HU (1) HU187734B (fr)
NZ (1) NZ200917A (fr)
WO (1) WO1982004396A1 (fr)
ZA (1) ZA824091B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8303994D0 (en) * 1983-02-14 1983-03-16 Council Of Governors Of United Antigenic materials
US5225344A (en) * 1983-02-15 1993-07-06 Kitasato Kenkyusho Non-cariogenic composition and drink
US5240704A (en) * 1983-07-03 1993-08-31 Kitasato Kenkyusho Vaccine, antibodies & antibody-containing compositions for inhibiting human dental caries induced by streptococcus mutans
JPS6028937A (ja) * 1983-07-25 1985-02-14 Kitasato Inst:The 非う蝕性抗体および組成物
JPS6038329A (ja) * 1983-08-11 1985-02-27 Lion Corp う蝕予防剤
US4693888A (en) * 1983-08-11 1987-09-15 Lion Corporation Caries-preventive composition
FR2581877B1 (fr) * 1985-05-14 1987-12-18 Louvain Universite Catholique Conjugue constitue d'une adhesine de paroi de s. mutans, de nature proteique et d'un polysaccharide de s. mutans, sa preparation et son utilisation notamment dans des vaccins anti-caries
JPH0699291B2 (ja) * 1985-06-14 1994-12-07 ライオン株式会社 口腔用組成物
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US5352446A (en) * 1986-03-25 1994-10-04 Council Of Governors Of The United Medical And Dental Schools Of Guy's And St. Thomas's Hospitals Method of treating dental caries with monoclonal antibodies against the antigen I and antigen I/II of streptococcus mutans
NO902352L (no) * 1989-05-29 1990-11-30 Lion Corp Fremgangsmaate for fremstilling av en vaksine mot dental karies, samt vaksineblandinger for anvendelse som nesedraaper
AU613857B3 (en) * 1990-07-10 1991-06-25 Geoffrey Ernest Smith Methods for manufacture and use of autogenous anti-tooth decay vaccines
WO1995015497A1 (fr) * 1993-11-30 1995-06-08 The University Of Queensland Dosage immunologique pour la detection du cancer du col de l'uterus
CA2243730C (fr) * 1997-07-29 2009-12-22 Akzo Nobel N.V. Vaccin contre streptococcus equi
US6682745B1 (en) * 1998-07-28 2004-01-27 Christiaan Antonius Arnoldus Jacobs Use of bacterium for manufacture of a vaccine
US6231857B1 (en) 1998-09-28 2001-05-15 The Regents Of The University Of California Antibodies to S. mutans and uses thereof
ES2214217T3 (es) * 1999-01-26 2004-09-16 Akzo Nobel N.V. Utilizacion de bacterias vivas atenuadas para la preparacion de una vacuna de administracion por la submucosa.
US6923962B2 (en) * 2000-04-10 2005-08-02 Dennis Cvitkovitch Signal peptides, nucleic acid molecules and methods for treatment of caries
US7556807B2 (en) * 2001-02-20 2009-07-07 Kane Biotech, Inc. Signal peptides, nucleic acid molecules and methods for treatment of caries
US7597895B2 (en) * 2001-02-20 2009-10-06 The Governing Council Of The University Of Toronto Signal peptides, nucleic acid molecules and methods for treatment of caries
US20050123490A1 (en) * 2003-12-04 2005-06-09 Kazue Yamagishi Composition and method for prevention and treatment of dental caries
US7875598B2 (en) * 2004-03-04 2011-01-25 The Regents Of The University Of California Compositions useful for the treatment of microbial infections
CA2957056A1 (fr) * 2006-09-06 2008-03-13 C3 Jian, Inc. Peptides antimicrobiens cibles selectivement et leur utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1375866A (fr) * 1971-06-11 1974-11-27
US4150116A (en) * 1978-02-21 1979-04-17 Forsyth Dental Infirmary For Children Immunization against dental caries with glucosyltransferase antigens
ZA794413B (en) * 1978-09-01 1980-08-27 Us Government Protection against dental caries
GB2033223B (en) * 1978-09-01 1983-09-14 Secr Social Service Brit Antigen fromstreptococcus mutans for protection against dental caries
GB2060647B (en) * 1979-10-18 1983-04-13 Russell M W Antigens ex streptococcus mutans
US4250262A (en) * 1979-12-14 1981-02-10 Forsyth Dental Infirmary For Children Method of preparing a purified glucosyltransferase

Also Published As

Publication number Publication date
JPS58500948A (ja) 1983-06-09
HU187734B (en) 1986-02-28
EP0068660A1 (fr) 1983-01-05
FI77983B (fi) 1989-02-28
FI830552A0 (fi) 1983-02-18
NZ200917A (en) 1985-03-20
WO1982004396A1 (fr) 1982-12-23
FI830552L (fi) 1983-02-18
AU556184B2 (en) 1986-10-23
US4521513A (en) 1985-06-04
CS455882A2 (en) 1985-09-17
DE3263103D1 (en) 1985-05-23
DK54483D0 (da) 1983-02-09
CA1204384A (fr) 1986-05-13
EP0068660B1 (fr) 1985-04-17
FI77983C (fi) 1989-06-12
ZA824091B (en) 1983-04-27
DK54483A (da) 1983-02-09
AU8459182A (en) 1983-01-04

Similar Documents

Publication Publication Date Title
CS244906B2 (en) Production method of antigen agent for limitation or prevention of tooth defects
EP0648127B1 (fr) Antigenes de surface du type i associes au staphylococcus epidermidis
EP0009872B1 (fr) Préparation d'antigène, procédé pour sa préparation et préparations pharmacologiques ou dentaires contenant la préparation d'antigène ou ses anticorps
EP0656014B1 (fr) Proteine de surface cellulaire appelee proteine rib qui immunise contre plusieurs souches de streptocoques du groupe b; procede de purification de la proteine rib, trousse de reactifs et composition pharmaceutique
PT90310B (pt) Processo para a obtencao de preparacoes de adenilato-ciclase
RU2186582C2 (ru) Способ выделения и очистки белка внешней мембраны moraxella catarrhalis, штамм м.catarrhalis для получения белка cd, изолированный и очищенный неденатурированный белок cd внешней мембраны м.catarrhalis и иммуногенная композиция, содержащая белок cd внешней мембраны м.сatarrhalis
GB2182937A (en) Common antigen (psc-a)to pseudomonas aeruginosa
KR900000546B1 (ko) 녹농균의 E 87 Ag 항원 및 그것에 대한 모노클로날 항체 및 하이브리도마
EP0761819A1 (fr) Exopolysaccharides du burkholderia pseudomallei et burkholderia mallei
WO1983003354A1 (fr) Vaccin anti-neisseria gonorrhoeae
CA1110968A (fr) Complexe antigenique de n. gonorrhoeae
US5114712A (en) Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for protecting Pseudomonas aeruginosa infection
NO161355B (no) Fremgangsmaate for fremstilling av et antigenpreparat mot dental caries.
AU681130C (en) Protein rib, a cell surface protein that confers immunity tomany strains of the group B streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
JPWO1986005396A1 (ja) 抗緑膿菌モノクローナル抗体，その製造法および緑膿菌感染症治療剤
HK1008825B (en) Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition